Skip to content
10-Q/A

Quarterly Report

ARYA SCIENCES ACQUISITION CORP V

0001140361-22-010238

← back to feed
Filed
Mar 18, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$762.26K
Cash And Equivalents Q3 2021 · Sep 30, 2021 $844.7K
Cash And Equivalents Q3 2021 · Feb 22, 2021 $0
Stockholders Equity Q3 2021 · Sep 30, 2021 −$4.06M
Stockholders Equity Q3 2021 · Jun 30, 2021 $8.51K
Stockholders Equity Q3 2021 · Mar 31, 2021 $15.71K
Stockholders Equity Q3 2021 · Feb 22, 2021 $0
Current Liabilities Q3 2021 · Sep 30, 2021 $226.35K
Total Liabilities Q3 2021 · Sep 30, 2021 $5.46M
Current Assets Q3 2021 · Sep 30, 2021 $1.38M
Total Assets Q3 2021 · Sep 30, 2021 $150.9M
Sga Expense Q3 2021 · Sep 30, 2021 $363.78K
Sga Expense Q3 2021 · Sep 30, 2021 $380.27K
Net Income Q3 2021 · Sep 30, 2021 −$349.24K
Net Income Q3 2021 · Sep 30, 2021 −$365.74K
Net Income Q3 2021 · Jun 30, 2021 −$7.2K
Net Income Q3 2021 · Mar 31, 2021 −$9.29K
Operating Income Q3 2021 · Sep 30, 2021 −$363.78K
Operating Income Q3 2021 · Sep 30, 2021 −$380.27K